The DOI matches its Crossref record.
Selective reduction of V α 14+ NK T cells associated with disease development in autoimmune-prone mice
Abstract
A novel peripheral T cell subset characterized by the expression of a NK marker and invariant TCR encoded by V α 14 J α 281 gene segments with a 1-base N-region was investigated in relation to autoimmune disease development. First, we observed that invariant V α 14+ NK T cells are specifically reduced with aging in C57BL/6 lpr/lpr or MRL lpr/lpr mice, whereas no change was observed in age-matched control C57BL/6 or MRL +/+ mice as determined by FACS analysis and RNase protection assay. This reduction precedes the disease development and could also be detected in other autoimmune disease-prone mice, such as C3H gld/gld and (NZB x NZW)F1 mice. These results suggest that the specific decrease in invariant V α 14+ NK T cells correlates strongly with the development of autoimmunity. Second, injection of MRL lpr/lpr mice with anti-V α 14 mAb resulted in the early onset and exacerbation of lymphosplenomegaly due to the accumulation of abnormal CD3+ B220+ CD4-CD8- T cells as well as an increase in the titers of anti-dsDNA autoantibodies. These results indicate that V α 14+ NK T cells regulate autoimmune responses and play a crucial role in controlling the development of autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Self-citationMOUSE CD1-SPECIFIC NK1 T CELLS: Development, Specificity, and Function
Bendelac, A., Rivera, M. N., Park, S.-H., & Roark, J. H. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.535 · Cited by 1,326
Going both ways: Immune regulation via CD1d-dependent NKT cells
Godfrey, D. I., & Kronenberg, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423594 · Cited by 877
Miyamoto, K., Miyake, S., & Yamamura, T. (2001) · Nature · doi:10.1038/35097097 · Cited by 874
NKT cells: facts, functions and fallacies
Godfrey, D. I., Hammond, K. J. L., Poulton, L. D., Smyth, M. J., & Baxter, A. G. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01735-7 · Cited by 858
Gumperz, J. E., Miyake, S., Yamamura, T., & Brenner, M. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011786 · Cited by 781
THE CD1 SYSTEM: Antigen-Presenting Molecules for T Cell Recognition of Lipids and Glycolipids
Porcelli, S. A., & Modlin, R. L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.297 · Cited by 704
The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
Delovitch, T. L., & Singh, B. (1997) · Immunity · doi:10.1016/s1074-7613(00)80392-1 · Cited by 676
The Regulatory Role of Vα14 NKT Cells in Innate and Acquired Immune Response
Taniguchi, M., Harada, M., Kojo, S., Nakayama, T., & Wakao, H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141057 · Cited by 669
Self-citationExtreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
Wilson, S. B., Kent, S. C., Patton, K. T., Orban, T., Jackson, R. A., Exley, M., Porcelli, S., Schatz, D. A., Atkinson, M. A., Balk, S. P., et al. (1998) · Nature · doi:10.1038/34419 · Cited by 646
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin‐Su, K., Ten, S., Sanz, M. M., Exley, M. A., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13605 · Cited by 640
Tilloy, F., Treiner, E., Park, S.-H., Garcia, C., Lemonnier, F., de la Salle, H., Bendelac, A., Bonneville, M., & Lantz, O. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.12.1907 · Cited by 615
CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4
Mendiratta, S. K., Martin, W. D., Hong, S., Boesteanu, A., Joyce, S., & Van Kaer, L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80290-3 · Cited by 595
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin-Su, K., Ten, S., Sanz, M., Exley, M., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213605 · Cited by 566
Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells
Exley, M., Garcia, J., Balk, S. P., & Porcelli, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.109 · Cited by 531
Impaired NK1+ T Cell Development and Early IL-4 Production in CD1-Deficient Mice
Chen, Y.-H., Chiu, N. M., Mandal, M., Wang, N., & Wang, C.-R. (1997) · Immunity · doi:10.1016/s1074-7613(00)80289-7 · Cited by 486
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Sato, H., Kondo, E., Harada, M., Koseki, H., Nakayama, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5690 · Cited by 476
Self-citationHammond, K. J. L., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I., & Baxter, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1047 · Cited by 474
CD1d-restricted Recognition of Synthetic Glycolipid Antigens by Human Natural Killer T Cells
Spada, F. M., Koezuka, Y., & Porcelli, S. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1529 · Cited by 438
Kaneko, Y., Harada, M., Kawano, T., Yamashita, M., Shibata, Y., Gejyo, F., Nakayama, T., & Taniguchi, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.105 · Cited by 396
Self-citationLehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J.-F., & Monteiro, R. C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1831 · Cited by 393
Natural Killer T Cell Activation Protects Mice Against Experimental Autoimmune Encephalomyelitis
Singh, A. K., Wilson, M. T., Hong, S., Olivares-Villagómez, D., Du, C., Stanic, A. K., Joyce, S., Sriram, S., Koezuka, Y., & Van Kaer, L. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1801 · Cited by 386
Loss of IFN-γ Production by Invariant NK T Cells in Advanced Cancer
Muhammad Ali Tahir, S., Cheng, O., Shaulov, A., Koezuka, Y., Bubley, G. J., Wilson, S. B., Balk, S. P., & Exley, M. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.4046 · Cited by 386
Lin, H.-H., Faunce, D. E., Stacey, M., Terajewicz, A., Nakamura, T., Zhang-Hoover, J., Kerley, M., Mucenski, M. L., Gordon, S., & Stein-Streilein, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042307 · Cited by 385
Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells
Zhang, B.-N., Yamamura, T., Kondo, T., Fujiwara, M., & Tabira, T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.10.1677 · Cited by 364
Sonoda, K.-H., Exley, M., Snapper, S., Balk, S. P., & Stein-Streilein, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1215 · Cited by 354
Burdin, N., Brossay, L., Koezuka, Y., Smiley, S. T., Grusby, M. J., Gui, M., Taniguchi, M., Hayakawa, K., & Kronenberg, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3271 · Cited by 334
Self-citationImmunity, tolerance and autoimmunity in the liver: A comprehensive review
Doherty, D. G. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.020 · Cited by 314
α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles
Kaer, L. V. (2005) · Nature Reviews Immunology · doi:10.1038/nri1531 · Cited by 299
Naumov, Y. N., Bahjat, K. S., Gausling, R., Abraham, R., Exley, M. A., Koezuka, Y., Balk, S. B., Strominger, J. L., Clare-Salzer, M., & Wilson, S. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251531798 · Cited by 293
Jahng, A. W., Maricic, I., Pedersen, B., Burdin, N., Naidenko, O., Kronenberg, M., Koezuka, Y., & Kumar, V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1789 · Cited by 291
Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity
Wilson, S. B., & Delovitch, T. L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1028 · Cited by 272
van der Vliet, H. J. J., von Blomberg, B. M. E., Nishi, N., Reijm, M., Voskuyl, A. E., van Bodegraven, A. A., Polman, C. H., Rustemeyer, T., Lips, P., van den Eertwegh, A. J. M., et al. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5060 · Cited by 268
α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria
Gonzalez-Aseguinolaza, G., de Oliveira, C., Tomaska, M., Hong, S., Bruna-Romero, O., Nakayama, T., Taniguchi, M., Bendelac, A., Van Kaer, L., Koezuka, Y., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8461 · Cited by 262
Self-citationNKT cells are phenotypically and functionally diverse
Hammond, K. J. L., Pelikan, S. B., Crowe, N. Y., Randle-Barrett, E., Nakayama, T., Taniguchi, M., Smyth, M. J., van Driel, I. R., Scollay, R., Baxter, A. G., et al. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3768::aid-immu3768>3.0.co;2-g · Cited by 262
Self-citationIllés, Z., Kondo, T., Newcombe, J., Oka, N., Tabira, T., & Yamamura, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4375 · Cited by 257
STEIN-STREILEIN, J., & STREILEIN, J. W. (2002) · International Reviews of Immunology · doi:10.1080/08830180212066 · Cited by 218
Metadata
- Authors
- Mieza, M. A., Itoh, T., Cui, J. Q., Makino, Y., Kawano, T., Tsuchida, K., Koike, T., Shirai, T., Yagita, H., Matsuzawa, A., Koseki, H., & Taniguchi, M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-05
- Volume
- 156
- Issue
- 10
- Pages
- 4035-4040
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2116180955
- Cited by
- 286
- References
- 0
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.